A Clinical Study to Assess the Efficacy and Safety of SED80 for Use in Cataract Surgery
NCT ID: NCT04711213
Last Updated: 2021-01-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
60 participants
INTERVENTIONAL
2020-09-14
2020-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Study to Assess the Efficacy and Safety of Dexamethasone Suspension for Cataract Surgery
NCT03687931
OCS-01 in Treating Inflammation and Pain in Post-cataract Patients
NCT04130802
"A Prospective Study of the Efficacy of Intracameral Dexamethasone (Dexycu™) Compared to Standard of Care Treatment for Post-Cataract Surgical Pain and Anterior Chamber Inflammation"
NCT04781335
Study to Evaluate the Safety for the Treatment of Inflammation Associated With Cataract Surgery
NCT02547623
A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery
NCT04205916
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dexamethasone Dose 1
Dexamethasone Dose 1
Dexamethasone ophthalmic suspension dose 1
Dexamethasone Dose 2
Dexamethasone Dose 2
Dexamethasone ophthalmic suspension dose 2
Placebo Dose 1
Placebo Dose 1
Placebo suspension dose 1
Placebo Dose 2
Placebo Dose 2
Placebo suspension dose 2
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexamethasone Dose 1
Dexamethasone ophthalmic suspension dose 1
Dexamethasone Dose 2
Dexamethasone ophthalmic suspension dose 2
Placebo Dose 1
Placebo suspension dose 1
Placebo Dose 2
Placebo suspension dose 2
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
iDrop, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gabriel Casada, MD
Role: PRINCIPAL_INVESTIGATOR
President - Centre De. Oftalmolgia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre De. Oftalmologia
San Salvador, , El Salvador
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.